Investigation of insulin loaded self-assembled microtubules for drug release

Bioconjugate Chemistry

Volumn 19, Issue 12, 2008, Pages 2394-2400

  Henricus, Marsiyana M ^a   Johnson, Karen T ^a   Banerjee, Ipsita A ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DICHROISM SPECTROSCOPY; CONTROLLED DRUG DELIVERY; DICHROISM; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PEPTIDES; TARGETED DRUG DELIVERY;

AFM; CONCENTRATION-DEPENDENT; CONFORMATION CHANGE; DRUG DELIVERY DEVICES; DRUG RELEASE; FTIR SPECTROSCOPY; MICROTUBULES; PH RANGE; PH-DEPENDENT; ZETA POTENTIAL ANALYSIS;

INSULIN;

BIS(N ALPHA AMIDOTYROSYLTYROSYLTYROSINE) 1,5 PENTANE DICARBOXYLATE; CARBOXYLIC ACID DERIVATIVE; INSULIN; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; INSULIN RELEASE; MOLECULAR INTERACTION; NONHUMAN; STOMACH PH; ZETA POTENTIAL;

EID: 58149090295     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800254n     Document Type: Article

References (52)

1. Lim, S., Wei, J., Li, Q., and You, J. (2005) A glucose biosensor based on electrodeposition of palladium nanoparticles and glucose oxidase onto Nafion-solubilized carbon nanotube electrode. Biosens. Bioelectron. 20, 2341-2346.
2. Balandin, A., Pokatilov, P., and Nika, D. (2007) Phonon engineering in hetero- and nanostructures. J. Nanoelectron. Optoelectron. 2, 140-170.
3. 2 nanotube catalysts for methanol electro-oxidation. J. Solid State Chem. 178, 1996-2000.
4. Couvreur, P., Dubernetc, C., and Puisieux, F. (1995) Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharm. Biopharm. 41, 2-13.
5. Emerich, D., and Thanos, C. (2006) The pinpoint promise of nanoparticles-based drug delivery and molecular diagnosis. Biomol. Eng. 23, 171-184.
6. Staples, M., Daniel, K., Cima, M., and Langer, R. (2006) Application of micro- and nano-electromechanical devices to drug delivery. Pharm. Res. 23, 847-863.
7. LaVan, D., McGuire, T., and Langer, R. (2003) Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 21, 1184-1191.
8. Oh, K., Lee, K., Han, S., Cho, S., Kim, D., and Yu, S. (2005) Formation of core/shell nanoparticles with a lipid core and their application as a drug delivery system. Biomacromolecules 6, 1062-1067.
9. Yih, T. C., and Al-Fandi, M. (2006) Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 97, 1184-1190.
10. Raghuvanshi, R., Mistra, A., Talwar, G., Levy, R., and Labhasetwar, V. (2001) Enhanced immune response with combination of alum and biodegradable nanoparticles containing tetanus toxoid. J. Microencapsulation 18, 723-732.
11. Kreuter, J., Ramage, P., Petrov, V., Hamm, S., Alyautdin, R., Briesen, H., and Begley, D. (2003) Direct evidence that poly-sorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm. Res. 20, 409-416.
12. Malmsten, M. (2006) Soft drug delivery systems. Soft Matter 2, 760-769.
13. Jr. Cudic, M., Chua, B., Deliyannis, G., and Jackson, D. (2004) An insect antibacterial peptide based drug delivery system. Mol. Pharm. 1, 220-232.
14. Teng, X., Shchukin, D., and Mohwald, H. (2008) A novel drug carrier: lipophilic drug loaded polyglutamate/polyelectrolyte nanocontainers. Langmuir 24, 383-389.
15. Malzert-Freon, A., Vrignaud, S., Saulnier, P., Lisowski, V., Benoit, J., and Rault, S. (2006) Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. Int. J. Pharm. 320, 157-164.
16. Yamaguchi, T. (1996) Lipid microspheres as drug carriers: a pharmaceutical point of view. Adv. Drug Delivery Rev. 20, 117-130.
17. Igarashi, R., Takenaga, M., and Matsuda, T. (1996) Distribution of lipid microsphere preparations. Adv. Drug Delivery Rev. 20, 147-154.
18. Mizushima, Y. (1996) Lipid microspheres (lipid emulsions) as a drug carrier-an overview. Adv. Drug Delivery Rev. 20, 113-115.
19. Mayer, L., Hope, M., and Cullis, P. (1986) Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858, 161-168.
20. Fang, J., Leu, Y., Chang, C., Lin, C., and Tsai, Y. (2004) Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Delivery 11, 97-105.
21. Katre, N., Asherman, J., Schaefer, H., and Hora, M. (1998) Multivesicular liposome (DepoFoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). J. Pharm. Sci. 87, 1341-1346.
22. Oh, K., Han, S., Lee, H., Koo, H., Kim, R., Lee, K., Han, S., Cho, S., and Yuk, S. (2006) Core/shell nanoparticles with Lecithin lipid cores for protein delivery. Biomacromolecules 7, 2362-2367.
23. Goldstein, A., Amory, J., Martin, S., Vernon, C., Matsumoto, A., and Yager, P. (2001) Testosterone delivery using glutamidebased complex high axial ratio microstructures. Bioorg. Med. Chem. 9, 2819-2825.
24. Venkatesan, N., Yoshimitsu, J., Ito, Y., Shibata, N., and Takada, K. (2005) Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials 26, 7154-7163.
25. Baughman, R., Zakhido, A., and deHeer, W. (2002) Carbon nanotubes - the route toward applications. Science 297, 787-792.
26. Iijima, S., and Ichihashi, T. (1993) Single-shell carbon nanotubes of 1 nm diameter. Nature 363, 603-605.
27. Kam, N., Jessop, T., Wender, P., and Dai, H. (2004) Nanotube molecular transporters: internalization of carbon nanotubes-protein conjugates to mammalian cells. J. Am. Chem. Soc. 126, 6850-6851.
28. Menzenski, M. Z., and Banerjee, I. A. (2007) Self-assembly of supramolecular nanostructures from phenyalanine derived bolaamphiphiles. New J. Chem. 31, 1674-1680.
29. Spear, R. L., Tamayev, R., Fath, K. R., and Banerjee, I. A. (2007) Templated growth of calcium phosphate on tyrosine derived microtubules and their biocompatibility. Colloids Surf., B 60, 158-166.
30. Yu, L., Banerjee, I. A., Gao, X., Nuraje, N., and Matsui, H. (2005) Fabrication and application of enzyme-incorporated peptide nanotubes. Bioconjugate Chem. 16, 1484-1487.
31. Reaven, G. (1997) Role of insulin resistance in human disease. Nutrition 13 (1), 64.
32. Brange, J., and Havelund, S. (1983) Insulin pumps and insulin quality: Requirements and problems. Acta Med. Scand. Suppl. 671, 135-138.
33. Brange, J., and Langkjær, L. (1993) Insulin structure and stability, In Stability and Characterization of Protein and Peptide Drugs: Case Histories (Wang, Y. J., and Pearlman, R., Eds.) pp 315-350, Plenum Press, New York.
34. Wu, C.-S., and Yang, J. T. (1981) Conformation of insulin and its fragments in surfactant solutions. Biochim. Biophys. Acta 667, 285-293.
35. Wang, Y., and Hanson, M. (1988) Parenteral formulations of proteins and peptides: stability and stabilizers. J. Parenteral Sci. Technol. 42, S3-S25.
36. Jain, D., and Majumdar, D. K. (2006) Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. J. Biomater. Appl. 21, 195-211.
37. Nolan, C., Gelbaum, L., and Lyon, L. (2006) H NMR investigation of thermally triggered insulin release from poly(N-isopropylacrylamide) microgels. Biomacromolecules 7, 2918-2922.
38. Ito, Y., Chung, D., and Imanishi, Y. (1994) Design and synthesis of a protein device that releases insulin in response to glucose concentration. Bioconjugate Chem. 5, 84-87.
39. Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., and Neufeld, R. (2007) Oral bioavailabilty of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8, 3054-3060.
40. Simon, M., Wittmar, M., Bakowsky, U., and Kissel, T. (2004) Self-assembling nanocomplexes from insulin and water-soluable branched polyesters, poly[(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-vinyl alcohol)]-graft-poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides. Bioconjuate Chem. 15, 841-849.
41. Bringer, J., Heldt, A., and Grodsky, G. M. (1981) Prevention of insulin aggregation by dicarboxylic amino acids during prolonged infusion. Diabetes 30, 83-85.
42. Kogiso, M., Ohnishi, S., Yase, K., Masuda, M., and Shimizu, T. (1998) Dicarboxylic oligopeptide bolaamphiphiles: proton-triggered self-assembly of microtubes with loose solid surfaces. Langmuir 14, 4978-4986.
43. Ninfa, J., and Ballou, D. (2008) Quantification of Protein Concentration, Fundamental Laboratory Approaches for Biochemistry and Biotechnology, pp 83-88, Chapter 3, Wiley, New York.
44. Caruso, F., Trau, D., Mohwald, H., and Renneberg, R. (2000) Enzyme encapsulation in layer-by-layer engineered polymer multilayer capsules. Langmuir 16, 1485-1488.
45. Djalali, R., Chen, Y., and Matsui, H. (2003) Au nano-crystal growth on nanotubes controlled by conformations and charges of sequenced peptide templates. J. Am. Chem. Soc. 125, 5873-5879.
46. Yu, L., Banerjee, I. A., Shima, M., Rajan, K., and Matsui, H. (2004) Size-controlled Ni nanocrystal growth on peptide nanotubes and their magnetic properties. Adv. Mater. 16, 709-712.
47. Pittman, I., and Tager, H. S. (1995) A spectroscopic investigation of the conformational dynamics of insulin in solution. Biochemistry. 34, 10578-10590.
48. Tiyaboonchai, W., Woiszwillo, J., Sims, R. C., and Middaugh, R. C. (2003) Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int. J. Pharm. 255, 139-151.
49. Aboubakar, M., Puisieux, F., Couvreur, P., and Vauthier, C. (1999) Physico-chemical characterization of insulin-loaded poly-(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Int. J. Pharm. 183, 63-66.
50. Xu, X., Li, H., Wang, C., Wu, T., and Han, S. (2004) Is the blue shift of C-H vibration in DMF-water mixture mainly caused by C-H--O interaction. Chem. Phys. Lett. 394, 405-409.
51. Dzwolak, W., Loksztejn, A., and Smirnovas, V. (2006) New insights into the self-assembly of insulin amyloid fibrils: An H-D exchange FT-IR study. Biochemistry 45, 8143-8151.
52. Dorkoosh, F., Verhoef, J., Amgats, M., Rafiee-Tehrani, M., Borchard, G., and Junginger, H. E. (2002) Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin. Eur. J. Pharm. Sci. 15, 433-439.